Breakthrough tablet coater from Niro Pharma
Niro Pharma Systems is launching a new tablet-coating system that promises to achieve a step forward in the evenness of tablet coating and make the production of small batches for R&D more cost-effective.
The firm's SuperCell Coating Technology is designed to accurately deposit coating materials on tablets, "even if they are friable or hygroscopic," and can handle batch sizes as little as 30gr. A spokesman for the company said that the system, due for its first official unveiling in Europe at the upcoming Interpack exhibition, is in the latter stages of development.
NPS claims that conventional methods of tablet-coating have inconsistent and imperfect results, leading to no regular results which can affect the behavior of the tablet. This can impart an element of variability that gains in significance if a small run of tablets is being produced for clinical trials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze